Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Seizure After COVID-19 Vaccination in a Patient on Clozapine.
Makhlouf AT, Van Alphen MU, Manzano GS, Freudenreich O. Makhlouf AT, et al. Among authors: freudenreich o. J Clin Psychopharmacol. 2021 Nov-Dec 01;41(6):689-690. doi: 10.1097/JCP.0000000000001488. J Clin Psychopharmacol. 2021. PMID: 34735102 No abstract available.
Optimal Long-Acting Injectable Antipsychotic Management During COVID-19.
MacLaurin SA, Mulligan C, Van Alphen MU, Freudenreich O. MacLaurin SA, et al. Among authors: freudenreich o. J Clin Psychiatry. 2021 Jan 12;82(1):20l13730. doi: 10.4088/JCP.20l13730. J Clin Psychiatry. 2021. PMID: 33434959 Free article. No abstract available.
Monitoring of clozapine blood levels in the real world.
Freudenreich O, McEvoy JP, Cooper TB. Freudenreich O, et al. J Clin Psychopharmacol. 1996 Feb;16(1):90-1. doi: 10.1097/00004714-199602000-00023. J Clin Psychopharmacol. 1996. PMID: 8834432 No abstract available.
Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial.
Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Fan X, et al. Among authors: freudenreich o. Psychopharmacology (Berl). 2019 Jun;236(6):1949-1957. doi: 10.1007/s00213-019-5181-z. Epub 2019 Feb 12. Psychopharmacology (Berl). 2019. PMID: 30747254 Clinical Trial.
Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia.
Wang J, Hart KL, Qi W, Ardekani BA, Li C, Marx J, Freudenreich O, Cather C, Holt D, Bello I, Diminich ED, Tang Y, Worthington M, Zeng B, Wu R, Fan X, Zhao J, Wang J, Goff DC. Wang J, et al. Among authors: freudenreich o. J Clin Psychopharmacol. 2021 May-Jun 01;41(3):244-249. doi: 10.1097/JCP.0000000000001391. J Clin Psychopharmacol. 2021. PMID: 33814546 Clinical Trial.
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.
Goff DC, Herz L, Posever T, Shih V, Tsai G, Henderson DC, Freudenreich O, Evins AE, Yovel I, Zhang H, Schoenfeld D. Goff DC, et al. Among authors: freudenreich o. Psychopharmacology (Berl). 2005 Apr;179(1):144-50. doi: 10.1007/s00213-004-2032-2. Epub 2004 Oct 21. Psychopharmacology (Berl). 2005. PMID: 15502972 Clinical Trial.
186 results